Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.5 (
RNase P
)
1,348
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A
ribonuclease P
-like activity was partially purified from HeLa cell mitochondria by DEAE-cellulose and octyl-Sepharose chromatography.
RNase P
-like activity can be quantitatively recovered from intact mitochondrial preparations treated with micrococcal nuclease, strongly suggesting that the enzyme is localized within the organelles. Mitochondrial
RNase P
(mtRNase P) cleaves the precursor to Escherichia coli suppressor tRNATyr at the same site as E. coli
RNase P
, producing the mature 5'-end of tRNATyr. The sensitivity of mtRNase P to pretreatment with nucleases or
Pronase
indicates that the enzyme has essential RNA and protein components. Although the ionic requirements of mtRNase P are similar to those of the
RNase P
activity isolated from the post-mitochondrial cytosol fraction, the chromatographic properties of mtRNase P are distinct. Mitochondrial
RNase P
is probably a part of the mitochondrial RNA processing machinery of mammalian mitochondria, being responsible for the endonucleolytic cleavage of the RNA transcripts at the 5'-side of the tRNA sequences.
...
PMID:Characterization of an RNase P activity from HeLa cell mitochondria. Comparison with the cytosol RNase P activity. 258 45